报道了新显色剂1-(2-苯并噻唑)-3-(2,4-二羟基苯)-三氮烯(BTDHBT)的合成及其与Cu(Ⅱ)的显色反应。研究了试剂与Cu(Ⅱ)的显色反应条件,建立了一个测定铜的光度分析新方法。在最佳实验条件下,反应在室温下放置10 m in的工作曲线的线性范围...报道了新显色剂1-(2-苯并噻唑)-3-(2,4-二羟基苯)-三氮烯(BTDHBT)的合成及其与Cu(Ⅱ)的显色反应。研究了试剂与Cu(Ⅱ)的显色反应条件,建立了一个测定铜的光度分析新方法。在最佳实验条件下,反应在室温下放置10 m in的工作曲线的线性范围为0.1~2.5μg/mL,回归方程为A=0.0644+0.074C(μg/L),相关系数r=0.9978,表观摩尔系数ε为30.7 m3/(mol.cm)。对2 mg/L Cu(Ⅱ)测定的相对标准偏差为1.16%(n=11),将方法用于铝合金样品中铜的测定,结果满意。展开更多
Aim To synthesize naturally occurring (-) methyl2,2-dimethyl-3-hydroxychromanyl-6-formate. Methods Sharpless' asymmetric dihydroxylation wasemployed to construct the 3-hydroxychroman. Results First asymmetric synt...Aim To synthesize naturally occurring (-) methyl2,2-dimethyl-3-hydroxychromanyl-6-formate. Methods Sharpless' asymmetric dihydroxylation wasemployed to construct the 3-hydroxychroman. Results First asymmetric synthesis of (-) methyl 2,2-dimethyl-3-hydroxychromanyl-6-formate (1) was accomplished starting from methyl 4-hydroxy-benzoate(2), and the absolute configuration was established. Conclusion A useful method for constructingchiral 3-hydroxychroman by employing Sharpless' asymmetric dihydroxylation is achieved.展开更多
3-(4-Hydroxyphenyl)-4-methyl-6-methoxy-7-hydroxycoumarin (2a) and its analogues with different substituents at the p-position of 3-phenyl group were designed and synthesized as the non-steroidal analogues of 2-met...3-(4-Hydroxyphenyl)-4-methyl-6-methoxy-7-hydroxycoumarin (2a) and its analogues with different substituents at the p-position of 3-phenyl group were designed and synthesized as the non-steroidal analogues of 2-methoxyestradiol (2-ME 1). The desired compounds were synthesized via a novel and simple route and the effects of specific substituents on their antiangiogenesis activities were investigated with Human umbilical vein endothelial cells (HUVECs) proliferation assays. Preliminary biological screening showed that compounds 2a and 2d (IC50 = 61.0 and 76.7 ktM, respectively) have potential anti-angiogenesis activities. The bulk of the group at the p-position of 3-phenyl group likely play an important role in their activities.展开更多
基金This research work was financially supported by the National Natural Science Foundation of China(Grant NO.20272020).
文摘Aim To synthesize naturally occurring (-) methyl2,2-dimethyl-3-hydroxychromanyl-6-formate. Methods Sharpless' asymmetric dihydroxylation wasemployed to construct the 3-hydroxychroman. Results First asymmetric synthesis of (-) methyl 2,2-dimethyl-3-hydroxychromanyl-6-formate (1) was accomplished starting from methyl 4-hydroxy-benzoate(2), and the absolute configuration was established. Conclusion A useful method for constructingchiral 3-hydroxychroman by employing Sharpless' asymmetric dihydroxylation is achieved.
文摘3-(4-Hydroxyphenyl)-4-methyl-6-methoxy-7-hydroxycoumarin (2a) and its analogues with different substituents at the p-position of 3-phenyl group were designed and synthesized as the non-steroidal analogues of 2-methoxyestradiol (2-ME 1). The desired compounds were synthesized via a novel and simple route and the effects of specific substituents on their antiangiogenesis activities were investigated with Human umbilical vein endothelial cells (HUVECs) proliferation assays. Preliminary biological screening showed that compounds 2a and 2d (IC50 = 61.0 and 76.7 ktM, respectively) have potential anti-angiogenesis activities. The bulk of the group at the p-position of 3-phenyl group likely play an important role in their activities.